Citius Oncology (CTOR) Operating Expenses (2023 - 2026)

Citius Oncology's Operating Expenses history runs 4 years deep, the most recent figure standing at $30.0 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 300.89% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at $48.0 million (up 159.61% YoY), while the FY2025 annual figure was $23.5 million, up 14.34% from the prior year.
• Operating Expenses was $30.0 million for Q1 2026 at Citius Oncology, up from $8.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $30.0 million in Q1 2026 to a low of $177922.0 in Q1 2023.
• Historically, Operating Expenses has averaged $6.4 million across 4 years, with a median of $4.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses surged 2536.86% in 2024, then climbed 6.83% in 2025.
• A 4-year view of Operating Expenses shows it stood at $4.6 million in 2023, then soared by 39.52% to $6.4 million in 2024, then jumped by 31.47% to $8.4 million in 2025, then surged by 256.27% to $30.0 million in 2026.
• The last three Operating Expenses figures came in at $30.0 million (Q1 2026), $8.4 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.